Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura

Transfusion. 2010 Mar;50(3):733-5. doi: 10.1111/j.1537-2995.2009.02497.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Recurrence
  • Rituximab
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab